Atovaquone-proguanil 250-100 100S
Ended Awarded Last action
- Contract number
- SPE2DR26FVYJ9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,763
Award facts
- Contract value 100% obligated
- $5,762.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $5,762.64 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100 (100 tablets), a combination antimalarial medication. The award, issued on January 16, 2026, is a firm fixed-price delivery order with an ultimate completion date of January 20, 2026. The contract utilizes no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as a comprehensive global pharmaceutical supply vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, regularly fulfills pharmaceutical and medical supply needs for military and veteran healthcare systems through competitively awarded delivery orders under this IDC vehicle. The Atovaquone-Proguanil order supports DLA's medical supply chain operations, providing essential antimalarial pharmaceuticals for military personnel and government healthcare beneficiaries. This transaction exemplifies the company's versatility in supplying diverse pharmaceutical products across multiple therapeutic domains through flexible pricing and delivery mechanisms aligned with federal healthcare procurement requirements.
Quick answers
Who was awarded contract SPE2DR26FVYJ9?
SPE2DR26FVYJ9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26FVYJ9 worth?
The government has obligated $5,763 on SPE2DR26FVYJ9.
Is contract SPE2DR26FVYJ9 an order under another contract?
Yes. SPE2DR26FVYJ9 is a delivery order under SPE2DR25D3002, an indefinite delivery contract.
Was contract SPE2DR26FVYJ9 competed?
The extent of competition for SPE2DR26FVYJ9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award